Please try another search
Can Fite Biofarma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. It's technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.
Name | Age | Since | Title |
---|---|---|---|
Pnina Fishman | 76 | 1994 | Founder, Chief Scientific Officer & Executive Chairperson |
Ilan Cohn | 69 | 1994 | Co-Founder & Director |
Abraham Sartani | 76 | 2001 | Independent Director |
Nabil Hanna | 79 | - | Member of Scientific Advisory Board |
Yaacov Goldman | 68 | 2017 | External Independent Director |
Stephen A. Harrison | - | 2023 | Member of Clinical Advisory Board & Consulting Chief Medical Officer |
Guy Regev | 54 | 2011 | Independent External Director |
Arun J. Sanyal | - | - | Member of Clinical Advisory Board |
Scott L. Friedman | - | - | Member of Clinical Advisory Board |
Yoseph Bornstein | 64 | 2021 | Independent External Director |
Rifaat Safadi | - | - | Member of Clinical Advisory Board |
Kim Papp | - | - | Member of Clinical Advisory Board |
Salomon Stemmer | - | - | Member of Clinical Advisory Board |
Ohad Etzion | - | - | Member of the Clinical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review